Breaking News Instant updates and real-time market news.

VRX

Ticker changed BHC

$15.37

0.24 (1.59%)

07:07
08/08/17
08/08
07:07
08/08/17
07:07

Valeant CEO says investments in core business 'delivering results'

"The investments we are making in our core business are delivering results. The Bausch + Lomb/International segment and Salix business, which together represented 73% of our revenue in the quarter, delivered strong organic growth, and we are continuing to reduce debt and resolve legacy issues. Additionally, we confirm that we are maintaining our 2017 full-year Adjusted EBITDA guidance range despite the impact of divestitures we've made this year," said CEO Joseph Papa.

  • 08

    Aug

  • 24

    Aug

VRX Ticker changed BHC
$15.37

0.24 (1.59%)

07/17/17
WELS
07/17/17
NO CHANGE
WELS
Underperform
Wells says Valeant selling Obagi for less than half of price paid in 2013
After Valeant announced it has agreed to sell its Obagi Medical Products business for $190M in cash, Wells Fargo analyst David Maris noted that this sale price is less than half of the $437M that the company paid to acquire Obagi in April 2013. While Valeant continues to make progress toward its asset sales and debt reduction targets, Maris does not believe that its recent divestitures have had a significant deleveraging impact. He keeps an Underperform rating on Valeant shares.
07/27/17
WELS
07/27/17
NO CHANGE
WELS
Underperform
Doctors not optimistic about Valeant's Siliq, says Wells Fargo
Wells Fargo analyst David Maris says the dozens of doctors he spoke to about Valeant Pharmaceuticals' Siliq are not optimistic. Over 50% of the physicians surveyed said they would use Siliq only as a fourth line therapy or later, Maris tells investors in a research note after Valeant announced the launch of the moderate-to-severe plaque psoriasis treatment. The analyst disagrees with Valeant management's claims that Siliq has "very large peak sales potential." The injection carries a warning about risk of suicide and Valeant will be competing against a large number of peers with greater resources, Maris argues. The analyst has an Underperform rating on Valeant shares, which are down 18c to $17.59 in midday trading.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.
08/04/17
WELS
08/04/17
NO CHANGE
WELS
Underperform
Valeant's Isuprel to face generic from Nexus, says Wells Fargo
Wells Fargo analyst David Maris noted that the FDA is reporting, and Nexus Pharmaceuticals has confirmed to him, that the company received approval for a generic version of Valeant's Isuprel. Nexus expects to "command the lion's share" of the U.S. market for the drug, as its version is made in the U.S. and has longer stability than Valeant's version, Maris tells investors. The analyst, who notes that Valeant previously indicated it anticipated that Isuprel would lose exclusivity in Q4, keeps an Underperform rating on the stock.

TODAY'S FREE FLY STORIES

BECN

Beacon Roofing

$36.71

-0.72 (-1.92%)

15:37
09/25/18
09/25
15:37
09/25/18
15:37
Conference/Events
Beacon Roofing management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AIR

AAR Corp.

$45.94

0.95 (2.11%)

15:34
09/25/18
09/25
15:34
09/25/18
15:34
Options
AAR Corp. options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SVMK

SurveyMonkey

$0.00

(0.00%)

15:33
09/25/18
09/25
15:33
09/25/18
15:33
Syndicate
SurveyMonkey aiming to price IPO above $9-$11 range, CNBC says »

CNBC cites sources on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ULTA

Ulta Beauty

$277.26

-3.75 (-1.33%)

15:25
09/25/18
09/25
15:25
09/25/18
15:25
Conference/Events
Cowen retail/luxury analyst to hold an analyst/industry conference call »

Retail/Luxury Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

CTAS

Cintas

$212.44

1.26 (0.60%)

15:19
09/25/18
09/25
15:19
09/25/18
15:19
Options
Cintas options imply 5.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/25/18
09/25
15:17
09/25/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/25/18
09/25
15:16
09/25/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$12.50

1.24 (11.01%)

15:12
09/25/18
09/25
15:12
09/25/18
15:12
Hot Stocks
FTE Networks CEO says on track to meet or exceed 2018 revenue view of $350M »

FTE Networks provided a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$38.93

-0.77 (-1.94%)

, TRI

Thomson Reuters

$45.70

0.25 (0.55%)

15:11
09/25/18
09/25
15:11
09/25/18
15:11
Periodicals
Breaking Periodicals news story on Blackstone, Thomson Reuters »

Blackstone mulling sale…

BX

Blackstone

$38.93

-0.77 (-1.94%)

TRI

Thomson Reuters

$45.70

0.25 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 22

    Oct

WH

Wyndham Hotels & Resorts

$55.42

0.27 (0.49%)

15:10
09/25/18
09/25
15:10
09/25/18
15:10
Conference/Events
Wyndham Hotels & Resorts management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

JCI

Johnson Controls

$35.65

-0.58 (-1.60%)

15:10
09/25/18
09/25
15:10
09/25/18
15:10
Options
Notable call spread in Johnson Controls »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
09/25/18
09/25
15:10
09/25/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

JBL

Jabil

$27.51

-2.57 (-8.54%)

15:08
09/25/18
09/25
15:08
09/25/18
15:08
Recommendations
Jabil analyst commentary  »

Jabil should be bought on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 09

    Oct

  • 13

    Nov

CMTL

Comtech

$34.73

0.77 (2.27%)

15:08
09/25/18
09/25
15:08
09/25/18
15:08
Hot Stocks
Comtech awarded over $4M in additional funding from U.S. Army »

Comtech announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

KBH

KB Home

$25.35

-0.18 (-0.71%)

15:04
09/25/18
09/25
15:04
09/25/18
15:04
Options
KB Home options imply 8.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MYGN

Myriad Genetics

$46.92

0.01 (0.02%)

15:00
09/25/18
09/25
15:00
09/25/18
15:00
Conference/Events
Myriad Genetics management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

DAL

Delta Air Lines

$57.10

-0.33 (-0.57%)

15:00
09/25/18
09/25
15:00
09/25/18
15:00
Options
Delta draws a notable call spread as shares tick lower »

Delta draws a notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

APRN

Blue Apron

$1.71

0.04 (2.40%)

14:57
09/25/18
09/25
14:57
09/25/18
14:57
Hot Stocks
Blue Apron jumps after O'Leary discusses on CNBC »

Shares of Blue Apron are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$200.71

-2.74 (-1.35%)

, CVS

CVS Health

$77.64

-1.1 (-1.40%)

14:54
09/25/18
09/25
14:54
09/25/18
14:54
Hot Stocks
NY DFS expresses concerns about proposed Aetna, CVS Health deal »

In a letter dated…

AET

Aetna

$200.71

-2.74 (-1.35%)

CVS

CVS Health

$77.64

-1.1 (-1.40%)

ESRX

Express Scripts

$93.26

-1.19 (-1.26%)

CI

Cigna

$200.54

-2.61 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 15

    Oct

ABT

Abbott

$72.00

0.57 (0.80%)

14:50
09/25/18
09/25
14:50
09/25/18
14:50
Hot Stocks
Abbott says study shows Portico safely reduced severe aortic stenosis »

Abbott announced one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

NKE

Nike

$85.02

0.75 (0.89%)

14:49
09/25/18
09/25
14:49
09/25/18
14:49
Options
Nike options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EZPW

Ezcorp

$10.58

0.075 (0.71%)

14:45
09/25/18
09/25
14:45
09/25/18
14:45
Conference/Events
Ezcorp management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 06

    Nov

CNDT

Conduent

$22.30

0.12 (0.54%)

14:37
09/25/18
09/25
14:37
09/25/18
14:37
Conference/Events
Conduent management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

INTC

Intel

$46.14

-0.77 (-1.64%)

, ADI

Analog Devices

$92.82

-2.19 (-2.31%)

14:36
09/25/18
09/25
14:36
09/25/18
14:36
Hot Stocks
Intel slides as analyst says sell with semis seen in cyclical downturn »

Shares of Intel (INTC)…

INTC

Intel

$46.14

-0.77 (-1.64%)

ADI

Analog Devices

$92.82

-2.19 (-2.31%)

MCHP

Microchip

$79.10

-3.19 (-3.88%)

ON

ON Semiconductor

$18.44

-0.665 (-3.48%)

MPWR

Monolithic Power

$129.88

-2.99 (-2.25%)

AMD

AMD

$32.59

-0.03 (-0.09%)

NVDA

Nvidia

$268.05

2.33 (0.88%)

QCOM

Qualcomm

$73.16

-0.43 (-0.58%)

SIMO

Silicon Motion

$54.13

-0.04 (-0.07%)

MXIM

Maxim Integrated

$58.13

-1.61 (-2.70%)

TXN

Texas Instruments

$107.78

-2.03 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 08

    Oct

  • 22

    Oct

  • 10

    Dec

  • 08

    May

BRC

Brady

$44.20

0.15 (0.34%)

14:35
09/25/18
09/25
14:35
09/25/18
14:35
Hot Stocks
Brady director Elizabeth Bruno sells over $1M in company stock »

Brady director Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.